Literature DB >> 20956994

Complementary medicine use by men with prostate cancer: a systematic review of prevalence studies.

F L Bishop1, A Rea, H Lewith, Y K Chan, J Saville, P Prescott, E von Elm, G T Lewith.   

Abstract

Men with prostate cancer are reported as commonly using complementary and alternative medicine (CAM) but surveys have not recently been subjected to a rigorous systematic review incorporating quality assessment. Six electronic databases were searched using pre-defined terms. Detailed information was extracted systematically from each relevant article. Study reporting quality was assessed using a quality assessment tool, which demonstrated acceptable inter-rater reliability and produces a percentage score. In all, 42 studies are reviewed. All were published in English between 1999 and 2009; 60% were conducted in the United States. The reporting quality was mixed (median score = 66%, range 23-94%). Significant heterogeneity precluded formal meta-analysis. In all, 39 studies covering 11,736 men reported overall prevalence of CAM use; this ranged from 8 to 90% (median=30%). In all, 10 studies reported prevalence of CAM use specifically for cancer care; this ranged from 8 to 50% (median = 30%). Some evidence suggested CAM use is more common in men with higher education/incomes and more severe disease. The prevalence of CAM use among men with prostate cancer varies greatly across studies. Future studies should use standardised and validated data collection techniques to reduce bias and enhance comparability.

Entities:  

Mesh:

Year:  2010        PMID: 20956994     DOI: 10.1038/pcan.2010.38

Source DB:  PubMed          Journal:  Prostate Cancer Prostatic Dis        ISSN: 1365-7852            Impact factor:   5.554


  20 in total

1.  A Placebo-Controlled Double-Blinded Randomized Pilot Study of Combination Phytotherapy in Biochemically Recurrent Prostate Cancer.

Authors:  M Diana van Die; Scott G Williams; Jon Emery; Kerry M Bone; Jeremy M G Taylor; Elizabeth Lusk; Marie V Pirotta
Journal:  Prostate       Date:  2017-02-09       Impact factor: 4.104

Review 2.  A critical review of complementary and alternative medicine use among people with arthritis: a focus upon prevalence, cost, user profiles, motivation, decision-making, perceived benefits and communication.

Authors:  Lu Yang; David Sibbritt; Jon Adams
Journal:  Rheumatol Int       Date:  2016-11-26       Impact factor: 2.631

3.  Complementary and alternative medicine use, patient-reported outcomes, and treatment satisfaction among men with localized prostate cancer.

Authors:  Scott D Ramsey; Steven B Zeliadt; David K Blough; Catherine R Fedorenko; Megan E Fairweather; Cara L McDermott; David F Penson; Stephen K Van Den Eeden; Ann S Hamilton; Neeraj K Arora
Journal:  Urology       Date:  2012-05       Impact factor: 2.649

4.  Trends in Complementary and Alternative Medicine Use among Patients with Prostate Cancer.

Authors:  Kyle B Zuniga; Shoujun Zhao; Stacey A Kenfield; Benjamin Cedars; Janet E Cowan; Erin L Van Blarigan; Jeanette M Broering; Peter R Carroll; June M Chan
Journal:  J Urol       Date:  2019-09-06       Impact factor: 7.450

5.  A randomized, double-blind, placebo-controlled study of the effects of pomegranate extract on rising PSA levels in men following primary therapy for prostate cancer.

Authors:  A J Pantuck; C A Pettaway; R Dreicer; J Corman; A Katz; A Ho; W Aronson; W Clark; G Simmons; D Heber
Journal:  Prostate Cancer Prostatic Dis       Date:  2015-07-14       Impact factor: 5.554

6.  A double-blind, randomized, neoadjuvant study of the tissue effects of POMx pills in men with prostate cancer before radical prostatectomy.

Authors:  Stephen J Freedland; Michael Carducci; Nils Kroeger; Alan Partin; Jian-Yu Rao; Yusheng Jin; Susan Kerkoutian; Hong Wu; Yunfeng Li; Patricia Creel; Kelly Mundy; Robin Gurganus; Helen Fedor; Serina A King; Yanjun Zhang; David Heber; Allan J Pantuck
Journal:  Cancer Prev Res (Phila)       Date:  2013-08-28

Review 7.  Prevalence of the Use of Herbal Medicines among Patients with Cancer: A Systematic Review and Meta-Analysis.

Authors:  John Baptist Asiimwe; Prakash B Nagendrappa; Esther C Atukunda; Mauda M Kamatenesi; Grace Nambozi; Casim U Tolo; Patrick E Ogwang; Ahmed M Sarki
Journal:  Evid Based Complement Alternat Med       Date:  2021-05-17       Impact factor: 2.650

8.  Pomegranate Extracts in the Management of Men's Urologic Health: Scientific Rationale and Preclinical and Clinical Data.

Authors:  Nils Kroeger; Kroeger N; A S Belldegrun; Belldegrun A S; A J Pantuck; Pantuck A J
Journal:  Evid Based Complement Alternat Med       Date:  2013-03-26       Impact factor: 2.629

9.  Fatty acid and phytosterol content of commercial saw palmetto supplements.

Authors:  Kavitha Penugonda; Brian L Lindshield
Journal:  Nutrients       Date:  2013-09-13       Impact factor: 5.717

10.  Use of complementary and alternative medicine before and after organ removal due to urologic cancer.

Authors:  Jens Mani; Eva Juengel; Ilhan Arslan; Georg Bartsch; Natalie Filmann; Hanns Ackermann; Karen Nelson; Axel Haferkamp; Tobias Engl; Roman A Blaheta
Journal:  Patient Prefer Adherence       Date:  2015-10-01       Impact factor: 2.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.